Item 5. Market for Registrant’s Common Equity
Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Our common stock is traded under the symbol “ENSG” on the NASDAQ Global Select Market. As of January 30, 2026, there were approximately 392 holders of record of our common stock.
Notwithstanding anything to the contrary set forth in any of our filings under the Securities Act or the Exchange Act that might incorporate future filings, including the Annual Report on Form 10-K, in whole or in part, the Stock Performance Graph and supporting data which follows shall not be deemed to be incorporated by reference into any such filings except to the extent that we specifically incorporate any such information into any such future filings.
The graph below shows the cumulative total stockholder return of investment of $100 (and the reinvestment of any dividends thereafter) on December 31, 2020 in (i) our common stock, (ii) the NASDAQ Composite Index, (iii) our peer group and (iv) the S&P 400 Healthcare Sector. Our stock price performance shown in the graph below is not indicative of future stock price performance.
The S&P 400 Healthcare Sector has been added to the performance graph for the fiscal year ended December 31, 2025, and we plan to include it in the future filings, as we believe the S&P 400 Health Care Sector provides a broader and more representative public industry index that includes companies operated within the healthcare industry.
72
Table of Contents
COMPARISON OF 60 MONTH CUMULATIVE TOTAL RETURN*
Among Ensign Group, the NASDAQ Composite Index, Our Peer Group and the S&P 400 Healthcare Sector
December 2025
*Assumes $100 invested on December 31, 2020 in stock in index, including reinvestment of dividends.
Fiscal year ended December 31.
2020 2021 2022 2023 2024 2025
The Ensign Group, Inc.
$ 100.00 $ 115.42 $ 130.38 $ 154.95 $ 183.82 $ 241.38
NASDAQ Composite Index
100.00 122.18 82.43 119.22 154.48 187.14
Peer Group (1)
100.00 104.69 88.97 115.61 159.88 228.38
S&P 400 Health Care 100.00 111.35 89.02 89.48 94.19 99.29
(1) The current composition of our Peer Group is as follows: Amedysis, Inc., CareTrust REIT Inc., Encompass Healthcare Corp., LTC Properties, Inc., National Healthcare Corporation, National Health Investors, Inc., Omega Healthcare Investors, Inc., PACS Group, Inc., Select Medical Holdings Corp. and Welltower Inc.
Dividend Policy
We do not have a formal dividend policy, but we currently intend to continue to pay regular quarterly dividends to the holders of our common stock. We have been a dividend-paying company since 2002 and have increased our dividend every year for the last 23 years.
Issuer Repurchases of Equity Securities
Stock Repurchase Programs — On May 15, 2025, the Board of Directors approved a stock repurchase program pursuant to which we are authorized to repurchase up to $20.0 million of our common stock under the program for a period of approximately 12 months from June 16, 2025. During the year ended December 31, 2025, we did not repurchase any shares pursuant to this stock repurchase program.
On February 21, 2025, the Board of Directors approved a stock repurchase program pursuant to which we were authorized to repurchase up to $20.0 million of our common stock under the program for a period of approximately 12 months from March 26, 2025. During the year ended December 31, 2025, we repurchased 157 shares of our common stock for $20.0 million. This repurchase program expired upon the repurchase of the fully authorized amount under the plan and is no longer in effect.
73
Table of Contents
A summary of the repurchase activity for the year ended December 31, 2025 (dollars in millions, shares in thousands, except per share amounts):
Period Total Number of Shares Repurchased (1)
Average Price Per Share (2)
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
First quarter of 2025
84 $ 128.33 $ 9.2
Second quarter of 2025
73 $ 125.94 $ 20.0
Third quarter of 2025
— $ — $ 20.0
October 1 to October 31, 2025
— $ — $ 20.0
November 1 to November 30, 2025
— $ — $ 20.0
December 1 to December 31, 2025
— $ — $ 20.0
(1) These purchases were effectuated through a Rule 10b5-1 trading plan adopted by the Company on February 21, 2025.
(2) The average price paid per share excludes any broker commissions.
Under our repurchase program, we are authorized to repurchase our issued and outstanding common shares from time to time in open-market and privately negotiated transactions, tender offers, pursuant to contractual provisions, and block trades, or otherwise in accordance with federal securities laws. The share repurchase program does not obligate us to acquire any specific number of shares. Any such repurchases will depend on our business strategy, prevailing market conditions, our liquidity requirements, contractual restrictions or covenants, compliance with securities laws, and other factors. The amounts involved in any such transaction may be material.
Item 6. [RESERVED]